Inventor
Annabelle BISCANS
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C12NMicroorganisms or enzymes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07HSugars8%
C12YEnzymes8%
PatentTitleYear
12,365,894Branched lipid conjugates of siRNA for specific tissue delivery202512,077,758Oligonucleotides for SARS-CoV-2 modulation202411,753,638Conjugated oligonucleotides202311,702,659Optimized anti-FLT1 oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to UNIV MASSACHUSETTS (4)· patent assignee history
2023Patents assigned to BETH ISRAEL DEACONESS MEDICAL CT INC (1)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV MASSACHUSETTS | 4 | 2023–2025 |
| BETH ISRAEL DEACONESS MEDICAL CT INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2025 |